Is yangxue qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension?

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Jie ^a   Yang, Xiaochen ^a   Feng, Bo ^a   Qian, Weidong ^b,c   Fang, Zhuyuan ^d   Liu, Wei ^a   Li, Haixia ^a   Li, Xiaoke ^e   Chu, Fuyong ^f   Xiong, Xingjiang ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c Department of Cardiology   (China)

^d Jiangsu Hospital of Traditional Chinese Medicine   (China)

^e BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHINESE DRUG; ENALAPRIL; INDAPAMIDE; UNCLASSIFIED DRUG; VALSARTAN; YANGXUE QINGNAO;

ANTIHYPERTENSIVE THERAPY; CONSTIPATION; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG GRANULE; EPIGASTRIC FULLNESS; ESSENTIAL HYPERTENSION; FATIGUE; HEADACHE; HUMAN; HYPOKALEMIA; NAUSEA; PAROXYSMAL HEADACHE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SORE THROAT; SYSTOLIC BLOOD PRESSURE;

EID: 84874906661     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/540613     Document Type: Review

References (57)

1. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
2. Roger V. L., Go A. S., Lloyd-Jones D.M., Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation 2011 123 e18 e209
3. Krause T., Lovibond K., Caulfield M., McCormack T., Williams B., Management of hypertension: summary of NICE guidance. British Medical Journal 2011 343 d4891 10.1136/bmj.d4891
4. Law M. R., Morris J. K., Wald N. J., Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. British Medical Journal 2009 338 b1665 2-s2.0-67649208013 10.1136/bmj.b1665
5. Cai L., Liu A. P., Zhang L., Li S. P., Wang P. Y., Prevalence, awareness, treatment, and control of hypertension among adults in Beijing, China. Clinical and Experimental Hypertension 2012 34 1 45 52
6. Chung N., Baek S., Chen M. F., Liau C. S., Park C. G., Park J., Saruta T., Shimamoto K., Wu Z., Zhu J., Fujita T., Expert recommendations on the challenges of hypertension in Asia. International Journal of Clinical Practice 2008 62 9 1306 1312 2-s2.0-49349114370 10.1111/j.1742-1241.2008.01838.x
7. Bell R. A., Suerken C. K., Grzywacz J. G., Lang W., Quandt S. A., Arcury T. A., CAM use among older adults age 65 or older with hypertension in the United States: general use and disease treatment. Journal of Alternative and Complementary Medicine 2006 12 9 903 909 2-s2.0-33751080093 10.1089/acm.2006.12. 903 (Pubitemid 44770983)
8. Chen K. J., Xu H., The integration of traditional Chinese medicine and western medicine. European Review 2003 11 225 235
9. Xu H., Chen K. J., Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese Journal of Integrative Medicine 2011 17 2 83 84 2-s2.0-79952558248 10.1007/s11655-011-0641-2
10. Chen K. J., Clinical service of Chinese medicine. Chinese Journal of Integrative Medicine 2008 14 3 163 164 2-s2.0-54549099086 10.1007/s11655-008- 0163-8
11. Wang J., Xiong X. J., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 10.1155/2012/268542 268542
12. Xu H., Chen K. J., Making evidence-based decisions in the clinical practice of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 6 483 485 2-s2.0-79952569703 10.1007/s11655-010-0560-7
13. Cheung F., TCM: made in China. Nature 2011 480 7378, supplement S82 S83
14. Xu H., Chen K., Integrative medicine: the experience from China. Journal of Alternative and Complementary Medicine 2008 14 1 3 7 2-s2.0-38749126248 10.1089/acm.2006.6329 (Pubitemid 351185427)
15. Wang J., Wang P. Q., Xiong X. J., Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Medicine 2012 10.4172/2165-8048.1000113
16. Wang J., Xiong X. J., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 10.1155/2012/284847 284847
17. Wang J., Yao K. W., Yang X. C., Liu W., Feng B., Ma J. Z., Du X. L., Wang P. Q., Xiong X. J., Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 10.1155/2012/714805 714805
18. Xu H., Chen K. J., Complementary and alternative medicine: is it possible to be mainstream? Chinese Journal of Integrative Medicine 2012 18 6 403 404
19. Lee M. S., Pittler M. H., Taylor-Piliae R. E., Ernst E., Tai chi for cardiovascular disease and its risk factors: a systematic review. Journal of Hypertension 2007 25 9 1974 1975 2-s2.0-34548426082 10.1097/HJH.0b013e32828cc8cd (Pubitemid 47356640)
20. Lee M. S., Pittler M. H., Guo R., Ernst E., Qigong for hypertension: a systematic review of randomized clinical trials. Journal of Hypertension 2007 25 8 1525 1532 2-s2.0-34447295616 10.1097/HJH.0b013e328092ee18 (Pubitemid 47056554)
21. Song M. X., Yang M., Newly Edited National Chinese Traditional Patent Medicines 2002 People's Health Publishing House
22. Gao Y., Reasonable Application Manual of Traditional Chinese Patent Medicine in Internal Medicine 2009 People's Health Publishing House
23. Zhu B. G., Clinical research on treating hypertension and its associated symptoms with Yangxue Qingnao granules. Zhong Yi Lin Chuang Yan Jiu 2012 4 7 55 56
24. Ye S. Y., Mao B. Y., Kang L. Y., Clinical effect of Yangxue Qingnao granules on hypertension. Tianjin Zhong Yi Yao 2004 21 5 377 379
25. Lu Y. J., Song H., Wang C. Q., Clinical effect of Yangxue Qingnao granules on hypertension complicated with carotid intimal medial thickness. Shandong Yi Yao 2008 48 28 41 42
26. Li J., Gao X. M., Zhang B. L., Kang L. Y., Guo Z. J., Fan G. W., Effect of Yangxue Qingnao granules on blood pressure and plasma levels of endothelin, calcitonin gene related peptide and NO in rats with renal hypertension. Zhong Yao Xin Yao Yu Lin Chuang Yao Li 2005 16 1 20 23
27. Guo Z. J., Gao X. M., Kang L. Y., Wang Y., Li J., Liu Y. P., Effect of Yangxue Qingnao granules on renal function of spontaneously hypertensive rats. Jilin Zhong Yi Yao 2010 30 8 730 731
28. Zhang Y. J., Gao X. M., Kang L. Y., Guo Z. J., Fan G. W., Effect of Yangxue Qingnao granules on blood pressure and brain gene expression profiles of spontaneously hypertensive rats. Zhong Cao Yao 2005 36 9 1375 1377
29. Higgins J. P. T., Green S., Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2009, http://www.cochrane-handbook.org/
30. Liu A. F., Yin J. Y., Meng X., Liu H., Effects of valsartan combined with Yangxue Qingnao Granule on 60 patients with primary hypertension. Shandong Yi Yao 2009 49 17 65 66
31. Chen W. F., Zhan D. M., Liu Y. H., Rehabilitation effects of Yangxue Qingnao Granule on hypertension. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2006 4 8 746 747
32. Ji R. L., Han Q. H., Effects of Yangxue Qingnao Granule on hypertension and associated symptoms. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2011 9 3 263 265
33. Yuan Z. Q., Effects of Yangxue Qingnao Granule on hypertension and headache. Zhongguo Xian Dai Yi Yao Za Zhi 2006 8 8 95 96
34. Shi C. E., Effects of Yangxue Qingnao Granule combined with felodipine on elderly patients with hypertension. Zhongguo Jian Kang Yue Kan 2011 30 2 47 48
35. Li Y., Wan Q. N., Effects of Yangxue Qingnao Granule combined with indapamide on 40 patients with isolated systolic hypertension. Zhongguo Zhong Yi Yao Xin Xi Za Zhi 2006 13 8 59 61
36. Liang L., Effects of Yangxue Qingnao Granule on hypertension. Zhongguo Xian Dai Yao Wu Ying Yong 2011 5 24 87 88
37. Fu Y., Xiao F., The curative observation on effect of Yangxue Qingnao granules on hypertension complication in 992 cases. Tianjin Zhong Yi Yao 2011 28 3 188 190
38. Yang S. L., Chen S. H., Liu X. Y., The effect of Yangxue Qingnao granules on 66 patients with hypertension complicated with insomnia. Shi Zhen Guo Yi Guo Yao 2008 19 10 2516
39. Lin C., Zhou X. H., "Clinical observation of Yangxue Qingnao Granule in treating hypertensive headache. Shanghai Zhong Yi Yao Za Zhi 2004 38 3 28
40. Ai C. M., Effects of Yangxue Qingnao Granule on 52 patients with hypertensive headache. Zhongguo Yi Yao Zhi Nan 2012 10 10 285 286
41. Qin H. P., Effect of Yangxue Qingnao Granule combined with enalapril on elderly patients with isolated systolic hypertension kidney damage. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2008 6 11 1363 1364
42. Wu T. X., Li Y. P., Bian Z. X., Li T. Q., Li J., Dagenais S., Moher D., Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM) (for solicitation of comments). Chinese Journal of Evidence-Based Medicine 2007 7 9 625 630 2-s2.0-35048864887 (Pubitemid 47555764)
43. Schulz K. F., Chalmers I., Hayes R., Altman D., Empirical evidence of bias. Journal of the American Medical Association 1995 273 408 412
44. Hu J., Zhang J. H., Zhao W., Zhang Y. L., Zhang L., Shang H. C., Cochrane systematic reviews of Chinese herbal medicines: an overview. Plos One 2011 6 12 10.1371/journal.pone.0028696 e28696
45. Junhua Z., Hongcai S., Xiumei G., Boli Z., Yaozu X., Hongbo C., Ming R., Methodology and reporting quality of systematic review/meta-analysis of traditional Chinese medicine. Journal of Alternative and Complementary Medicine 2007 13 8 797 805 2-s2.0-35948979969 10.1089/acm.2007.7195 (Pubitemid 350071613)
46. Chen W., Danforn Lin C. E., Kang H. J., Liu J. P., Chinese herbal medicines for the treatment of Type A H1N1 Influenza: a systematic review of randomized controlled trials. Plos One 2011 6 12 e28093
47. Tu Y. Y., The discovery of artemisinin (qinghaosu) and gift from Chinese medicine. Nature Medicine 2011 17 10 19 22
48. Liu L., The clinical trial barriers. Nature 2011 480 7378, supplement S100
49. Liu M. Y., Chen K. J., Convergence: the tradition and the modern. Chinese Journal of Integrative Medicine 2012 18 3 164 165
50. Shen Z. Y., Chen X., Analysis on 99 cases of adverse reactions of Chinese patent drugs. African Journal of Microbiology Research 2012 6 8 1742 1746
51. Xu H., Chen K. J., Herb-drug interaction: asn emerging issue of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 3 195 196 2-s2.0-78149421985 10.1007/s11655-010-0195-z
52. Tachjian A., Maria V., Jahangir A., Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases. Journal of the American College of Cardiology 2010 55 6 515 525 2-s2.0-75249084792 10.1016/j.jacc.2009. 07.074
53. Miller L. G., Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine 1998 158 20 2200 2211 2-s2.0-0032501120 10.1001/archinte.158.20.2200 (Pubitemid 28512494)
54. Adriane F. B., Herb-drug interactions. The Lancet 2000 355 134 138
55. Windrum P., Hull D. R., Morris T. C. M., Herb-drug interactions. The Lancet The 2000 355 9208 1019 1020 2-s2.0-0034681720 (Pubitemid 30148283)
56. Wang J., Xiong X., Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 697237 10.1155/2012/697237
57. The Consort Statement, http://www.consort-statement.org